These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15810901)

  • 21. When should patients with Alzheimer disease stop driving?
    Erten-Lyons D
    Neurology; 2008 Apr; 70(14):e45-47. PubMed ID: 18378878
    [No Abstract]   [Full Text] [Related]  

  • 22. Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease.
    de Jager CA
    Neurol Res; 2004 Jul; 26(5):481-7. PubMed ID: 15362213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Memory: therapeutic approach. Clinical evaluation].
    Pasquier F
    Therapie; 2000; 55(4):513-9. PubMed ID: 11098729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tacrine].
    Dávila C; Viteri C; de Castro P
    Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools?
    Snyder PJ; Kahle-Wrobleski K; Brannan S; Miller DS; Schindler RJ; DeSanti S; Ryan JM; Morrison G; Grundman M; Chandler J; Caselli RJ; Isaac M; Bain L; Carrillo MC
    Alzheimers Dement; 2014 Nov; 10(6):853-60. PubMed ID: 25458309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Unawareness of deficits in Alzheimer's disease: a multidimentional approach].
    Trouillet R; Gély-Nargeot MC; Derouesné C
    Psychol Neuropsychiatr Vieil; 2003 Jun; 1(2):99-110. PubMed ID: 15683946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild cognitive impairment: current research and clinical implications.
    Petersen RC
    Semin Neurol; 2007 Feb; 27(1):22-31. PubMed ID: 17226738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proper names in the early stages of Alzheimer's disease.
    Semenza C; Borgo F; Mondini S; Pasini M; Sgaramella T
    Brain Cogn; 2000; 43(1-3):384-7. PubMed ID: 10857731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease: diagnosis and treatment across the spectrum of disease severity.
    Neugroschl J; Wang S
    Mt Sinai J Med; 2011; 78(4):596-612. PubMed ID: 21748748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.
    Crook T
    Psychopharmacol Bull; 1988; 24(1):31-8. PubMed ID: 3290945
    [No Abstract]   [Full Text] [Related]  

  • 31. Neurocognitive differential diagnosis of dementing diseases: Alzheimer's Dementia, Vascular Dementia, Frontotemporal Dementia, and Major Depressive Disorder.
    Braaten AJ; Parsons TD; McCue R; Sellers A; Burns WJ
    Int J Neurosci; 2006 Nov; 116(11):1271-93. PubMed ID: 17000529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of semantic knowledge on the cognitive estimation task--evidence from Alzheimer's disease and healthy adult aging.
    Della Sala S; MacPherson SE; Phillips LH; Sacco L; Spinnler H
    J Neurol; 2004 Feb; 251(2):156-64. PubMed ID: 14991349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild cognitive impairment. Is it the first sign of Alzheimer's disease?
    Mayo Clin Health Lett; 2001 Aug; 19(8):1-3. PubMed ID: 11475591
    [No Abstract]   [Full Text] [Related]  

  • 34. [Guidelines for the medical treatment of patients with Alzheimer's disease].
    Guideline Subcommittee of the Taiwan Dementia Society
    Acta Neurol Taiwan; 2011 Jun; 20(2):85-100. PubMed ID: 21739387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can impairment in memory, language and executive functions predict neuropsychiatric symptoms in Alzheimer's disease (AD)? Findings from a cross-sectional study.
    García-Alberca JM; Lara JP; Berthier ML; Cruz B; Barbancho MÁ; Green C; González-Barón S
    Arch Gerontol Geriatr; 2011; 52(3):264-9. PubMed ID: 20570375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive topographical disorientation: a case of focal Alzheimer's disease.
    Grossi D; Fasanaro AM; Cecere R; Salzano S; Trojano L
    Neurol Sci; 2007 Apr; 28(2):107-10. PubMed ID: 17464476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How useful is the IQCODE for discriminating between Alzheimer's disease, mild cognitive impairment and subjective memory complaints?
    Sikkes SA; van den Berg MT; Knol DL; de Lange-de Klerk ES; Scheltens P; Uitdehaag BM; Klein M; Pijnenburg YA
    Dement Geriatr Cogn Disord; 2010; 30(5):411-6. PubMed ID: 21071942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease.
    Reisberg B; Gauthier S
    Int Psychogeriatr; 2008 Feb; 20(1):1-16. PubMed ID: 18072981
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessing the cognitive abilities that differentiate patients with Alzheimer's disease from normals: single and multiple factor models.
    Ownby RL; Loewenstein DA; Schram L; Acevedo A
    Int J Geriatr Psychiatry; 2004 Mar; 19(3):232-42. PubMed ID: 15027038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
    Harwood DG; Sultzer DL; Wheatley MV
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.